Pfizer Buys Two GSK Meningitis Vaccines for $130M
Deal adds two single-dose meningitis vaccines, Nimenrix and Mencevax, to buyer’s meningococcal disease portfolio
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
